GlassScriptPhysician profile
Michael J Archibeck
NPI 1528046885
$19,139.98
in general payments reported to CMS, 2019-2025
9 companies · $9,736 in 2025
The $9,736 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.06 · 2021: $209 · 2022: $3,236 · 2023: $2,909 · 2024: $3,032 · 2025: $9,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Education: $2,421 · Food and Beverage: $1,890 · Travel and Lodging: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,485.00 |
| Education | $2,420.72 |
| Food and Beverage | $1,890.28 |
| Travel and Lodging | $880.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $14,522.50 | 2021-2025 | Rosa, Comprehensive Shoulder System, Avenir |
| Synthes Gmbh | $3,040.74 | 2022 | |
| Stryker Corporation | $1,083.08 | 2021-2025 | Mako, Triathlon, Accolade |
| Smith+Nephew, INC. | $215.83 | 2021-2024 | Real Intelligence, Tandem, Journey II |
| Davol INC. | $93.15 | 2024 | |
| Depuy Synthes Sales INC. | $73.89 | 2021-2023 | Attune |
| Total Joint Orthopedics, INC. | $51.77 | 2025 | |
| Medacta USA, INC. | $40.96 | 2025 | M-Vizion |
| Djo, LLC | $18.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Archibeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.